Atogepant

157 interactions 1 explained in plain English 45 cited references
Also sold as: Qulipta Qulipta®
About Atogepant

Atogepant is a calcitonin gene-related peptide receptor antagonist used to help prevent migraine headaches. Read the full Atogepant drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 12, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Atogepant Enzalutamide Xtandi Reduced atogepant exposure Details Atogepant Erythromycin Erythrocin Stearate Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse effects Details Atogepant Eslicarbazepine Acetate Aptiom Reduced atogepant exposure Details Atogepant Etravirine Intelence Reduced atogepant exposure Details Atogepant Fluconazole Diflucan Increased sensitive CYP3A4 substrates exposure Details Atogepant Fosamprenavir Lexiva Reduced atogepant exposure Details Atogepant Fosphenytoin Cerebyx Reduced atogepant exposure Details Atogepant Fostemsavir Rukobia Increased atogepant exposure Details Atogepant Garlic Reduced atogepant exposure Details Atogepant Gemfibrozil Lopid Increased atogepant exposure Details Atogepant Ginkgo Reduced atogepant exposure Details Atogepant Ginseng Reduced atogepant exposure Details Atogepant Glecaprevir Increased atogepant exposure Details Atogepant Grazoprevir Increased atogepant exposure Details Atogepant Ibrexafungerp Brexafemme Increased atogepant exposure Details Atogepant Idelalisib Zydelig Increased atogepant exposure Details Atogepant Indinavir Increased atogepant exposure Details Atogepant Isavuconazole Reduced atogepant exposure Details Atogepant Isavuconazonium Cresemba Reduced atogepant exposure Details Atogepant Itraconazole Sporanox Increased atogepant exposure Details Atogepant Ivosidenib Tibsovo Reduced atogepant exposure Details Atogepant Ketoconazole Extina Increased atogepant exposure Details Atogepant Lenacapavir Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details Atogepant Leniolisib Joenja Increased OATP1B1/OATP1B3 substrate exposure Details Atogepant Lesinurad Reduced atogepant exposure Details Atogepant Letermovir Prevymis Increased atogepant exposure Details Atogepant Lonafarnib Zokinvy Increased atogepant exposure Details Atogepant Lorlatinib Lorbrena Reduced atogepant exposure Details Atogepant Lumacaftor Reduced atogepant exposure Details Atogepant Methylprednisolone Depo-Medrol Reduced atogepant exposure Details Atogepant Mifepristone Korlym Increased atogepant exposure Details Atogepant Mitapivat Aqvesme Reduced atogepant exposure Details Atogepant Mitotane Lysodren Reduced atogepant exposure Details Atogepant Mobocertinib Exkivity Reduced atogepant exposure Details Atogepant Modafinil Provigil Reduced atogepant exposure Details Atogepant Nafcillin Reduced atogepant exposure Details Atogepant Nefazodone Increased atogepant exposure Details Atogepant Nelfinavir Viracept Increased atogepant exposure Details Atogepant Nevirapine Viramune Reduced atogepant exposure Details Atogepant Omaveloxolone Skyclarys Reduced atogepant exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.